Reply of the authors: Enhancing women's health management for predicting miscarriage risk: a call for broader inclusivity and holistic approaches.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Reply of the authors: Enhancing women's health management for predicting miscarriage risk: a call for broader inclusivity and holistic approaches.
Συγγραφείς: Yland JJ; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts., Zad Z; Hariri Institute for Computing and Computational Science & Engineering, Boston University, Boston, Massachusetts; Division of Systems Engineering, Department of Electrical and Computer Engineering, Boston University, Boston, Massachusetts., Paschalidis IC; Hariri Institute for Computing and Computational Science & Engineering, Boston University, Boston, Massachusetts; Division of Systems Engineering, Department of Electrical and Computer Engineering, Boston University, Boston, Massachusetts; Department of Biomedical Engineering, Boston University, Boston, Massachusetts., Wise LA; Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.
Πηγή: Fertility and sterility [Fertil Steril] 2024 Dec; Vol. 122 (6), pp. 1161. Date of Electronic Publication: 2024 Aug 20.
Τύπος έκδοσης: Letter
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-5653 (Electronic) Linking ISSN: 00150282 NLM ISO Abbreviation: Fertil Steril Subsets: MEDLINE; In Process
Imprint Name(s): Publication: New York. NY : Elsevier for the American Society for Reproductive Medicine
Original Publication: New York, Hoeber.
Competing Interests: Declaration of Interests J.J.Y. has nothing to disclose. Z.Z. has nothing to disclose. I.C.P. has nothing to disclose. L.A.W. received in-kind donations from Swiss Precision Diagnostics and Kindara.com for primary data collection in Pregnancy Study Online and serves as a consultant for AbbVie, Inc., and the Gates Foundation.
Entry Date(s): Date Created: 20240822 Latest Revision: 20241205
Update Code: 20260130
DOI: 10.1016/j.fertnstert.2024.08.329
PMID: 39173702
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1556-5653
DOI:10.1016/j.fertnstert.2024.08.329